Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-13

Clinical Trial Update: IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis [NA]

View source ↗

Summary

This update notes the completion of a clinical study of IDA immunotherapy for adults with atopic dermatitis. The trial was sponsored by INSERM in France.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IDA (Immunothérapie de la Dermatite Atopique)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Atopic Dermatitis | NA | Status: COMPLETED